Novo Nordisk Group General Counsel & Senior Vice President John Kuckelman speaks with Bloomberg's Dani Burger and Isabelle Lee after the company on Tuesday accused rival Eli Lilly of misleading advertising. Novo says that Lilly’s advertising campaigns rely on outdated weight-loss comparisons with lower doses of Novo’s own obesity shot Wegovy than what’s currently available, according to the complaint.

Wells Fargo CEO Charlie Scharf Talks Economy, US Consumer, Earnings
14:47

AT&T CEO John Stankey Talks Earnings
11:40

Virginia Senator Mark Warner (D) Talks Risk of AI Taking Jobs
09:48